DRIO DarioHealth Corp

USD 1.52 0.01 0.330033
Icon

DarioHealth Corp (DRIO) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.52

+0.01 (+0.33)%

USD 0.04B

0.14M

N/A

USD 10.00 (+557.89%)

Icon

DRIO

DarioHealth Corp (USD)
COMMON STOCK | NSD
USD 1.52
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.04B

USD 10.00 (+557.89%)

USD 1.52

DarioHealth Corp (DRIO) Stock Forecast

N/A

Based on the DarioHealth Corp stock forecast from 0 analysts, the average analyst target price for DarioHealth Corp is not available over the next 12 months. DarioHealth Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of DarioHealth Corp is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, DarioHealth Corp’s stock price was USD 1.52. DarioHealth Corp’s stock price has changed by +8.57% over the past week, -29.30% over the past month and -62.47% over the last year.

No recent analyst target price found for DarioHealth Corp
No recent average analyst rating found for DarioHealth Corp

Company Overview DarioHealth Corp

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its user-centric multi-chronic condition digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven...Read More

https://www.dariohealth.com

18 West 18th Street, New York, NY, United States, 10011

241

December

USD

USA

Adjusted Closing Price for DarioHealth Corp (DRIO)

Loading...

Unadjusted Closing Price for DarioHealth Corp (DRIO)

Loading...

Share Trading Volume for DarioHealth Corp Shares

Loading...

Compare Performance of DarioHealth Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for DRIO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To DarioHealth Corp (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +8.97 (+1.69%) USD44.10B 52.65 36.72

ETFs Containing DRIO

Symbol Name DRIO's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About DarioHealth Corp (DRIO) Stock

Stock Target Advisor's fundamental analysis for DarioHealth Corp's stock is Slightly Bearish.

Unfortunately we do not have enough data on DRIO's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on DRIO's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on DRIO's stock to indicate if its overvalued.

The last closing price of DRIO's stock was USD 1.52.

The most recent market capitalization for DRIO is USD 0.04B.

Unfortunately we do not have enough analyst data on DRIO's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains DarioHealth Corp's stock.

As per our most recent records DarioHealth Corp has 241 Employees.

DarioHealth Corp's registered address is 18 West 18th Street, New York, NY, United States, 10011. You can get more information about it from DarioHealth Corp's website at https://www.dariohealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...